JG
REGN icon

Jain Global’s Regeneron Pharmaceuticals REGN Stock Holding History

Jain Global’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-22,662
Closed -$11.9M – 1413
2025
Q2 		$11.9M Buy
22,662
+6,520
+40% +$3.64M 0.09% 197
2025
Q1 		$10.2M Buy
16,142
+13,010
+415% +$8.95M 0.12% 132
2024
Q4 		$2.23M Buy
+3,132
New +$2.63M 0.07% 222

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jain Global's REGN Position: Q3 2025 in Review

Jain Global sold out of Regeneron Pharmaceuticals (REGN) in Q3 2025, closing a stake of 22,662 shares — an estimated $11.9M sold.

Jain Global first reported a position in REGN in Q4 2024 and held it in 3 quarters. The position peaked at $11.9M in Q2 2025. 1,244 funds tracked by Wall St. Rank hold REGN as of Q3 2025.

  • Jain Global reported no remaining Regeneron Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Jain Global sold 22,662 Regeneron Pharmaceuticals shares in Q3 2025, an estimated $11.9M.
  • Jain Global first reported a position in Regeneron Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • Jain Global's Regeneron Pharmaceuticals position peaked at $11.9M in Q2 2025.
  • 1,244 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.

Based on Jain Global's 13F filing for Q3 2025, filed 14 Nov 2025.